Logo

GenMark

UK Startup LEX Diagnostics Developing Ultra-Fast Low-Cost PCR for Infectious Disease Dx
Premium

At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.

Roche Diagnostics Q1 Sales Climb 50 Percent

The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year.

GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock

The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month.

Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing
Premium

Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.

Roche to Acquire GenMark Diagnostics for $1.8B

Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.

Mar 2, 2021

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Feb 26, 2021

GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission
Premium

Feb 25, 2021

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Feb 11, 2021

GenMark Shares Rise on Acquisition Rumors

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More

Jan 11, 2021

GenMark Diagnostics Preliminary Q4 Revenues Rise 84 Percent on ePlex Molecular Diagnostics Sales

Oct 29, 2020

GenMark Diagnostics Expanding Manufacturing to Meet Pent Up Demand for SARS-CoV-2, Respiratory Panel
Premium

Oct 28, 2020

GenMark Q3 Revenues More Than Double on Respiratory Panel Sales

Oct 8, 2020

GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization

Sep 14, 2020

GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Sep 1, 2020

Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 4, 2020

GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing

Jul 7, 2020

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests

Jul 2, 2020

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Jul 1, 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Jun 1, 2020

Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details

May 7, 2020

GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings

May 4, 2020

GenMark Diagnostics Q1 Revenues Grow 80 Percent

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.